FR531M - - Google Patents

Info

Publication number
FR531M
FR531M FR837316A FR837316A FR531M FR 531 M FR531 M FR 531M FR 837316 A FR837316 A FR 837316A FR 837316 A FR837316 A FR 837316A FR 531 M FR531 M FR 531M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR837316A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR798293A external-priority patent/FR1333707A/fr
Application filed filed Critical
Priority to FR837316A priority Critical patent/FR531M/fr
Application granted granted Critical
Publication of FR531M publication Critical patent/FR531M/fr
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR837316A 1958-07-10 1960-08-31 Active FR531M (cs)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR837316A FR531M (cs) 1958-07-10 1960-08-31

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB22148/58A GB851287A (en) 1958-07-10 1958-07-10 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof
FR798293A FR1333707A (fr) 1959-06-23 1959-06-23 Procédé de fabrication du 5-chlorotoluène-2,4-disulfamide et de ses sels alcalins
FR837316A FR531M (cs) 1958-07-10 1960-08-31

Publications (1)

Publication Number Publication Date
FR531M true FR531M (cs) 1961-05-23

Family

ID=10174686

Family Applications (1)

Application Number Title Priority Date Filing Date
FR837316A Active FR531M (cs) 1958-07-10 1960-08-31

Country Status (2)

Country Link
FR (1) FR531M (cs)
GB (1) GB851287A (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB959229A (en) * 1960-11-18 1964-05-27 Kyowa Hakko Kogyo Company Ltd Method for producing l-isoleucine by fermentation process
DE3068986D1 (en) * 1980-01-28 1984-09-27 Merck & Co Inc Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors
IE50901B1 (en) * 1980-03-04 1986-08-06 Merck & Co Inc Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
SK5992003A3 (en) 2000-11-21 2003-11-04 Sankyo Co Medicinal composition comprising an angiotensin II receptor antagonist and one or more diuretics and use thereof
ES2362998T3 (es) 2002-08-19 2011-07-18 Pfizer Inc. Terapia de combinación para enfermedades hiperproliferativas.
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
JP6422868B2 (ja) 2013-07-23 2018-11-14 第一三共株式会社 高血圧症の予防又は治療のための医薬
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Also Published As

Publication number Publication date
GB851287A (en) 1960-10-12

Similar Documents

Publication Publication Date Title
FR531M (cs)
AT214638B (cs)
AT217439B (cs)
AT216227B (cs)
AT213316B (cs)
AT213446B (cs)
AT213908B (cs)
AT215751B (cs)
AT213631B (cs)
AT213558B (cs)
AT213313B (cs)
AT216749B (cs)
AT216612B (cs)
AT216803B (cs)
AT216831B (cs)
AT213337B (cs)
AT219868B (cs)
AT215738B (cs)
AT217982B (cs)
AT216771B (cs)
AT214348B (cs)
AT214270B (cs)
AT219815B (cs)
AT213670B (cs)
AT213472B (cs)